Danaparoid for VTE prophylaxis
Danaparoid is approved for VTE prophylaxis for up to 10 days after total hip replacement or hip fracture surgery; for dosage, see the danaparoid product information. It is not widely used (except in patients with a history of heparin-induced thrombocytopenia [HIT]).
